Eli Lilly: Collaborating with NVIDIA to Build a Supercomputer for the Pharmaceutical Industry
On October 30th, Eli Lilly announced that it will collaborate with NVIDIA to build a supercomputer owned and operated by pharmaceutical companies
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments